Cargando…
Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients
The electrocardiogram (ECG) represents an essential tool to determine cardiac electrical abnormalities in COVID-19 patients, the effects of anti-SARS-CoV-2 drugs, and potential drug interactions. Smartphone-based heart monitors have increased the spectrum of ECG monitoring however, we are not aware...
Autores principales: | Zaballos, Matilde, Fernández, Ignacio, Rodríguez, Lucia, Orozco, Silvia, García, Amparo, Juncos, Mónica, Alvarez-Zaballos, Sara, Piñeiro, Patricia, Hortal, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326027/ https://www.ncbi.nlm.nih.gov/pubmed/37415069 http://dx.doi.org/10.1038/s41598-023-37688-8 |
Ejemplares similares
-
Comparison of Apple Watch vs KardiaMobile: A Tale of Two Devices
por: Lee, Calvin, et al.
Publicado: (2022) -
Increasing Early Cardiac Screening in an Inpatient Psychiatric Setting Using the KardiaMobile 6 Lead Device
por: Pierscionek, Tomasz, et al.
Publicado: (2023) -
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results
por: Goldenthal, Isaac L., et al.
Publicado: (2019) -
Improving the utility and sustainability of novel health technology to improve clinical outcomes for patients: an East Staffordshire experience of screening for atrial fibrillation with the AliveCor KardiaMobile
por: Mathew, Savio, et al.
Publicado: (2021) -
Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center
por: Koltowski, Lukasz, et al.
Publicado: (2021)